HIV RESEARCH CORE

艾滋病毒研究核心

• 批准号: 7960428
• 负责人: Cecilia M. Shikuma
• 金额: $ 40.27万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7960428
• 关键词: AIDS neuropathy; Acquired Immunodeficiency Syndrome; Burn injury; Clinical; Clinical Research; Clinical Trials Unit; Clinical and Translational Science Awards; Collaborations; Computer Retrieval of Information on Scientific Projects Database; Development; Education; Funding; Grant; HIV; HIV-1; Hawaii; Hospitals; Human Development; Infection; Institution; Malignant Neoplasms; Neurosciences Research; Patients; Population; Quality of life; Research; Research Infrastructure; Research Personnel; Resources; Services; Source; United States National Institutes of Health; Universities; clinical care; clinically relevant; improved; medical schools; programs

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The UH CRC program has expanded to include a HIV Research Core in affiliation with the Hawaii AIDS Clinical Research Program (HACRP) of the UH John A. Burns School of Medicine. Located at Leahi Hospital, the HACRP emphasizes HIV education, research, and service in accordance with the following specific aims: 1) To develop clinical research capabilities to evaluate optimal therapies for HIV-1 infection and AIDS-associated complications. 2) To provide access to clinical research, trials, and studies for all HIV-1 infected patients in Hawaii. 3) To facilitate the transfer of research findings to clinical care which will ultimately improve the quality of life for patients with HIV-1 infection. THe HACRP also includes the Hawaii AIDS Clinical Trials Unit (HACTU) and the NeuroAIDS Specialized Neuroscience Research Program (NeuroAIDS SNRP). This affiliation with the HACRP is in congruence with the specific aims of the UH CRC program, namely, to build and refine clinical excellence and expertise in Early Human Development, Bionutrition, HIV and Cancer, with particular emphasis on issues of clinical relevance to the populations of the State of Hawaii. Moreover, the development of the HIV Research Core with the HACRP gives evidence of research collaboration and partnership which will further strengthen the University of Hawaii's ability to compete for a NIH institutional Clinical Translational Science Award (CTSA).

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 UH CRC计划已经扩展到包括与UH John A.伯恩斯医学院。 设在Leahi医院的艾滋病毒防治方案强调艾滋病毒教育、研究和服务，具体目标如下： 1)发展临床研究能力，以评估HIV-1感染和艾滋病相关并发症的最佳疗法。 2)为夏威夷的所有HIV-1感染患者提供临床研究、试验和研究。 3)促进将研究成果转化为临床护理，最终改善HIV-1感染患者的生活质量。 该HACCP还包括夏威夷艾滋病临床试验单位（HACTU）和神经艾滋病专门神经科学研究计划（神经艾滋病SNRP）。 与HACCP的这种联系是在UH CRC程序的具体目标，即建立和完善临床卓越和专业知识在早期人类发展，生物营养素，艾滋病毒和癌症，特别强调临床相关的问题，以夏威夷州的人口一致。 此外，艾滋病毒研究核心与HACCP的发展提供了研究合作和伙伴关系的证据，这将进一步加强夏威夷大学竞争NIH机构临床转化科学奖（CTSA）的能力。